JPRN-UMIN000044672已完成未知
Comparative Efficacy and Safety of Tezepelumab and Dupilumab in Patients with Inadequately Controlled Asthma According to Thresholds of Type 2 Inflammatory Biomarkers: A Systematic Review and Network Meta-Analysis - Tezepelumab versus Dupilumab in asthma
Showa University School of Medicine0 个研究点目标入组 5,524 人开始时间: 2021年6月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5,524
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- 12years-old 至 100years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients under 12 years old Non-RCTs, phase 1, 2 or, non-phase 3 RCTs, case-control studies, and cohort studies.
研究者
相似试验
招募中
3 期
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Tezepelumab in Patients With Eosinophilic Esophagitis (CROSSING).Eosinophilic EsophagitisJPRN-jRCT2021230017Ageishi Yuji360
尚未招募
不适用
Comparisson of the effectiveness of Tocilizumab and Tofacitinib on the outcomes of patients with severe COVID-19COVID-19.COVID-19, virus identifiedU07.1IRCT20210901052358N3Shahid Beheshti University of Medical Sciences60
进行中（未招募）
1 期
Efficacy and safety of Bevacizumab/Temsirolimus combination after first-line Bevacizumab/IFN combination in advanced renal cell carcinomaAdvanced renal cancerMedDRA version: 12.1Level: LLTClassification code 10038390Term: Renal cancer recurrentEUCTR2010-020664-38-GRHellenic Cooperative Oncology Group
已完成
不适用
Efficacy and Safety of treatment with tocilizumab in refractory patients with Takayasu ArteritisTakayasu arteritisJPRN-UMIN000007845Department of Cardiovascular Medicine Graduate School of Medicine Osaka University15
招募中
不适用
Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patientsPrimary osteoprosisosteoprosisD0 1 0 0 2 4JPRN-jRCT1041200090Kobayakawa Tomonori150